Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9,1 million participants. Lancet 2011; 377: 557-567
DOI: 10.1016/S0140-6736(10)62037-5
Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002;8:1288–95
DOI: 10.1038/nm788
Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941–6
DOI: 10.1038/90984
Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79–83
DOI: 10.1006/bbrc.1999.0255
Duncan BB, Schmidt MI, Pankow JS, et al. Adiponectin and the development of type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes 2004;53:2473–8. 9.
DOI: 10.2337/diabetes.53.9.2473
Ryo M, Nakamura T, Kihara S, et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004;68:975–81
DOI: 10.1253/circj.68.975
de Luis DA, Aller R, Izaola O, Bachiller R. Role of rs6923761 gene variant in glucagon-like peptide 1 receptor in basal GLP-1 levels, cardiovascular risk factor and serum adipokine levels in naïve type 2 diabetic patients. J Endocrinol Invest. 2015;38:143-147.
DOI: 10.1007/s40618-014-0161-y
Yamagata K, Matsukawa Y, Okutomi K, Horie M, Shimomura I, K Hotta, H Kuriyama, S Kihara, T Nakamura, S Yamashita, T Funahashi, Y Matsuzawa. Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obes Relat Metab Disord. 2000; 24: 861–868
DOI: 10.1038/sj.ijo.0801244
Comuzzie AG, Funahashi T, Sonnenberg G. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab.2001;86:4321–4325
DOI: 10.1210/jcem.86.9.7878
de Luis DA, Primo D, Izaola O, Gómez E, Bachiller R. Serum Lipid and Adiponectin Improvements after a Mediterranean Dietary Pattern in Non-G-Allele Carriers of the Variant rs3774261. Lifestyle Genom. 2020;13:164-171.
DOI: 10.1159/000508819
Rasmussen-Torvik, L.J., Pankow, J.S., Jacobs Jr., D.R., Steinberger, J., Moran, A., Sinaiko, A.R. The association of SNPs in ADIPOQ, ADIPOR1, and ADIPOR2 with insulin sensitivity in a cohort of adolescents and their parents. Hum. Genet. 2009; 125, 21–28
DOI: 10.1007/s00439-008-0595-4
Salazar-Tortosa DF, Pascual-Gamarra JM, Labayen I, Rupérez AI, Censi L, Béghin L, Michels N, González-Gross M, Manios Y, Lambrinou CP, Moreno LA, Meirhaeghe A, Castillo MJ, Ruiz JR. Single nucleotide polymorphisms of ADIPOQ gene associated with cardiovascular disease risk factors in European adolescents: the Healthy Lifestyle in Europe by Nutrition in Adolescence study. J Hypertens. 2020;38:1971-1979.
DOI: 10.1097/HJH.0000000000002502
Primo D, Izaola O, de Luis D. Serum lipid and adiponectin/leptin ratio changes after a Mediterranean dietary pattern in non-g-allele carriers of the genetic variant of adiponectin gene rs822393. Eur Rev Med Pharmacol Sci. 2021;25:3489-3498
AlSaleh A, O'Dell SD, Frost GS, Griffin BA, Lovegrove JA, Jebb SA, Sanders TA; RISCK Study Group. Single nucleotide polymorphisms at the ADIPOQ gene locus interact with age and dietary intake of fat to determine serum adiponectin in subjects at risk of the metabolic syndrome. Am J Clin Nutr. 2011;94:262-9.
DOI: 10.3945/ajcn.111.014209
Mataix J, Mañas M. Tablas de composición de alimentos españoles. Ed: University of Granada, 2003
Friedewald WT, Levy RJ, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
DOI: 10.1093/clinchem/18.6.499
Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-414.
DOI: 10.1007/BF00280883
Meier U, Gressner M. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, Ghrelin, adiponectin, and resistin. Clinical Chemistry 2004; 50: 1511-1525.
DOI: 10.1373/clinchem.2004.032482
Pfutzner A, Langefeld M, Kunt T. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin Lab 2003; 49: 571-576.
Lukaski H, Johson PE. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985; 41: 810-817.
DOI: 10.1093/ajcn/41.4.810
Won HH, Natarajan P, Dobbyn A, Jordan DM, Roussos P, Lage K, Raychaudhuri S, Stahl E, Do R. Disproportionate Contributions of Select Genomic Compartments and Cell Types to Genetic Risk for Coronary Artery Disease. PLoS Genet. 2015;11:e1005622
DOI: 10.1371/journal.pgen.1005622
Christou GA, Kiortsis DN. Adiponectin and lipoprotein metabolism. Obes Rev. 2013;14:939-49
DOI: 10.1111/obr.12064
Wassel CL, Pankow JS, Jacobs DR Jr, Steffes MW, Li N, Schreiner PJ. Variants in the adiponectin gene and serum adiponectin: the Coronary Artery Development in Young Adults (CARDIA) Study. Obesity (Silver Spring). 2010;18:2333233-8.
DOI: 10.1038/oby.2010.85
Ramya K, Ayyappa KA, Ghosh S, Mohan V, Radha V. Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population. Gene. 2013 15;532:253-62.
DOI: 10.1016/j.gene.2013.09.012
Jacob AG, Smith CWJ. Intron retention as a component of regulated gene expression programs. Hum Genet. 2017;136:1043-1057
DOI: 10.1007/s00439-017-1791-x
Emerging Risk Factors Collaboration group. The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol. 2007;22:839-69
DOI: 10.1007/s10654-007-9165-7
Yanai H, Yoshida H. Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives. Int J Mol Sci. 2019;20: 1190.
DOI: 10.3390/ijms20051190
Jacob AG, Smith CWJ. Intron retention as a component of regulated gene expression programs. Hum Genet. 2017;136:1043-1057
DOI: 10.1007/s00439-017-1791-x
Primo D, Izaola O, de Luis D. Serum lipid and adiponectin/leptin ratio changes after a Mediterranean dietary pattern in non-g-allele carriers of the genetic variant of adiponectin gene rs822393. Eur Rev Med Pharmacol Sci. 2021;25:3489-3498
Izaola O, Primo D, de Luis D. Dietary intervention during 9months with a hypocaloric diet, interaction of the genetic variant of adiponectin gene rs822393 with metabolic parameters. In press
Kasim-Karakas SE, Tsodikov A, Singh U, Jialal I. Responses of inflammatory markers to a low-fat, high-carbohydrate diet: effects of energy intake. Am J Clin Nutr 2006;83:774–9
DOI: 10.1093/ajcn/83.4.774
Mejia-Montilla J, Reyna-Villasmil E, Domínguez-Brito L, Naranjo-Rodríguez C, Noriega-Verdugo D, Padilla-Samaniego M, Vargas-Olalla V. Supplementation with omega-3 fatty acids and plasma adiponectin in women with polycystic ovary syndrome. Endocrinol Diabetes Nutr (Engl Ed). 2018 ;65:192-199.
DOI: 10.1016/j.endien.2018.04.006
Yang X, Zhang Y, Lin J, Pen A, Ying C, Cao W, Mao L. A lower proportion of dietary saturated/monounsaturated/polyunsaturated fatty acids reduces the expression of adiponectin in rats fed a high-fat diet. Nutr Res. 2012 ;32:285-91.
DOI: 10.1016/j.nutres.2011.12.016
Larsen MA, Isaksen VT, Paulssen EJ, Goll R, Florholmen JR. Postprandial leptin and adiponectin in response to sugar and fat in obese and normal weight individuals. Endocrine. 2019; 66:517-525.
DOI: 10.1007/s12020-019-02102-9
Warodomwichit D, Shen J, Arnett DK, Tsai MY, Kabagambe EK, Peacock JM, Hixson JE, Straka RJ, Province MA, An P, Lai CQ, Parnell LD, Borecki IB, Ordovas JM. ADIPOQ polymorphisms, monounsaturated fatty acids, and obesity risk: the GOLDN study. Obesity (Silver Spring). 2009 ;17:510-7.
DOI: 10.1038/oby.2008.583
Frühbeck G, Catalán V, Rodríguez A, Ramírez B, Becerril S, Salvador J, Colina I, Gómez-Ambrosi J. Adiponectin-leptin Ratio is a Functional Biomarker of Adipose Tissue Inflammation. Nutrients. 2019 22;11:454.
DOI: 10.3390/nu11020454
Frühbeck G, Catalán V, Rodríguez A, Gómez-Ambrosi J. Adiponectin-leptin ratio: A promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk. Adipocyte. 2018 ;7:57-62.
DOI: 10.1080/21623945.2017.1402151